Oakland, CA, United States of America

Marc Andrew Garard

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cytokinetics, Inc., Astellas Pharma Gmbh. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Andrew Garard. Retrieved from https://idiyas.com/inventor/marc-andrew-garard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 15.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Oakland, CA (US) (2010)
  • San Leandro, CA (US) (2018 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Marc Andrew Garard - Innovative Inventor from Oakland

Introduction: Marc Andrew Garard is a talented inventor based in Oakland, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Marc Andrew Garard holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Marc Andrew Garard has consistently pushed the boundaries of innovation, leading to significant advancements in his respective fields.

Collaborations: Throughout his career, Marc Andrew Garard has collaborated with leading companies, research institutions, and universities to bring his inventions to life and make a positive impact on society.

Conclusion: Marc Andrew Garard's passion for innovation and his dedication to creating solutions for complex challenges have solidified his reputation as a pioneering inventor in Oakland and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…